Pharma CEO raises EpiPen price by 400%, and gets a 671% raise

From the outside perspective this seems like some sort of giant whack-a-mole. Instead of fixing the problem from the ground up (=patents, monopolies etc.) they only jump at every bogey-man/company that gets the media spotlight for being a bit too greedy.

5 Likes